Anticoagulant factor V: factors affecting the integration of novel scientific discoveries into the broader framework.
Since its initial discovery in the 1940s, factor V has long been viewed as an important procoagulant protein in the coagulation cascade. However, in the later part of the 20th century, two different scientists proposed novel anticoagulant roles for factor V. Philip Majerus proposed the first anticoagulant function for factor V in 1983, yet ultimately it was not widely accepted by the broader scientific community. In contrast, Björn Dahlbäck proposed a different anticoagulant role for factor V in 1994. While this role was initially contested, it was ultimately accepted and integrated into the scientific framework. In this paper, I present a detailed historical account of these two anticoagulant discoveries and propose three key reasons why Dahlbäck's anticoagulant role for factor V was accepted whereas Majerus' proposed role was largely overlooked. Perhaps most importantly, Dahlbäck's proposed anticoagulant role was of great clinical interest because the discovery involved the study of an important subset of patients with thrombophilia. Soon after Dahlbäck's 1994 work, this patient population was shown to possess the factor V Leiden mutation. Also key in the ultimate acceptance of the second proposed anticoagulant role was the persistence of the scientist who made the discovery and the interest in and ability of others to replicate and reinforce this work. This analysis of two different yet similar discoveries sheds light on factors that play an important role in how new discoveries are incorporated into the existing scientific framework.
Department of Biological Sciences, Wellesley College, 106 Central Street, Wellesley, MA 02481, USA. Electronic address: mlabonte@post.harvard.edu.
Michelle L
ML
LaBonte
D000925:Anticoagulants / Q000266:history* / Q000378:metabolism; D001777:Blood Coagulation; D005165:Factor V / Q000235:genetics / Q000266:history* / Q000378:metabolism; D049673:History, 20th Century; D006801:Humans; D009154:Mutation; D012586:Science / Q000266:history*; D019851:Thrombophilia / Q000266:history* / Q000378:metabolism
D000925:Anticoagulants; D005165:Factor V
Anticoagulant; Coagulation cascade; Factor V; Factor V Leiden; Thrombophilia